Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 397)
Posted On: 11/13/2020 8:55:58 PM
Post# of 36568
Posted By: Buildit
Took a quick look at the financials... not too exciting, as expected, but I had a couple of thoughts:

1) Assets under management - $2.5MM needed for $2 uplist - still ~$1.5MM; probably irrelevant, as we wouldn't meet some of the other qualifications for $2 listing... so we're still looking at $4, most likely IMO.

2) Stock payable - up from ~$1.1MM to $10.1MM. Not too significant if the shares achieve some sort of material value... but highly significant @ $0.20. This actually accounts for the bulk of the increase in Liabilities, so I suppose it could be worse.

3) Revenues rather insignificant @ ~$2.6MM. Interestingly, though, the gross profit was slightly higher than the previous year, when revs were $6.2MM, since the gross margin is so high. GM of ~78% is great, especially when the revs start to go up.

4) G&A expense down $4MM, and I would guess it will drop significantly if listings are achieved and ongoing deals are closed for good.


That's all I noticed in the financials in a quick look. All we need is material revenue, and I still think we'll be off to the races. Ha... "ALL we need"!

Have a good weekend, everybody!













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site